Albemarle Financial Statements From 2010 to 2024

AMC Stock  EUR 101.84  0.92  0.90%   
Albemarle financial statements provide useful quarterly and yearly information to potential Albemarle investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Albemarle financial statements helps investors assess Albemarle's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Albemarle's valuation are summarized below:
Albemarle does not presently have any fundamental signals for analysis.
Check Albemarle financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Albemarle's main balance sheet or income statement drivers, such as , as well as many indicators such as . Albemarle financial statements analysis is a perfect complement when working with Albemarle Valuation or Volatility modules.
  
This module can also supplement various Albemarle Technical models . Check out the analysis of Albemarle Correlation against competitors.

Albemarle Company Current Valuation Analysis

Albemarle's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Albemarle Current Valuation

    
  29.44 B  
Most of Albemarle's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Albemarle is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Albemarle has a Current Valuation of 29.44 B. This is 157.99% higher than that of the Basic Materials sector and 4.46% lower than that of the Specialty Chemicals industry. The current valuation for all Germany stocks is 77.06% lower than that of the firm.

Albemarle Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Albemarle's current stock value. Our valuation model uses many indicators to compare Albemarle value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Albemarle competition to find correlations between indicators driving Albemarle's intrinsic value. More Info.
Albemarle is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.30  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Albemarle is roughly  3.31 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Albemarle's earnings, one of the primary drivers of an investment's value.

About Albemarle Financial Statements

Albemarle stakeholders use historical fundamental indicators, such as Albemarle's revenue or net income, to determine how well the company is positioned to perform in the future. Although Albemarle investors may analyze each financial statement separately, they are all interrelated. For example, changes in Albemarle's assets and liabilities are reflected in the revenues and expenses on Albemarle's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Albemarle. Please read more on our technical analysis and fundamental analysis pages.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company was incorporated in 1993 and is headquartered in Charlotte, North Carolina. ALBEMARLE CORP operates under Specialty Chemicals classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5900 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Albemarle Stock

Albemarle financial ratios help investors to determine whether Albemarle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Albemarle with respect to the benefits of owning Albemarle security.